Abstract

Aim of the Study: The aim of this study was to study the circumstances of the risk of complications of a new coronavirus infection.

Materials and Methods: 148 patients with COVID-19 were examined, the patients were divided into 2 groups: the first group (60 people) had complications of coronavirus infection, and the second (88 patients) had no complications. The selection criterion was the presence of acute viral pneumonia and a confirmed diagnosis of COVID-19. The age of the patients is from 29 to 89 years. The values of ferritin, C-reactive protein, D-dimer, as well as concomitant diseases of the patients were analyzed. The factors influencing the development of complications of COVID-19 were studied.

Results: Significantly more often, COVID-19 was complicated in patients with grade II-III arterial hypertension, chronic kidney disease, obstructive pulmonary disease and postinfarction cardiosclerosis, as well as in the group of patients with complications, higher values of C-reactive protein, D-dimer and ferritin were observed (p < 0.05).

Conclusion: The development of a complicated course of a new coronavirus infection is facilitated by uncontrolled arterial hypertension, myocardial infarction, chronic lung and kidney pathology, as well as an increase in the level of markers of inflammation and thrombus formation.

Keywords: New Coronavirus Infection; Complications; Risk Factors

References

1. Aghagoli G., et al. “Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review”. Journal of Cardiac Surgery (2020).
2. Alhogbani T. “Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus”. Annals of Saudi Medicine 1 (2016): 78-80.
3. Bertolini A., et al. “Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis”. Hepatology (2020): 1-9.
4. Driggin E., et al. “Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic”. Journal of the American College of Cardiology 18 (2020): 2352-2371.
5. Li B., et al. “Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”. Clinical Research in Cardiology 5 (2020): 531-538.
6. Lodigiani C., et al. “Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy”. Thrombosis Research 191 (2020): 9-14.
7. Shi S., et al. “Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China”. JAMA Cardiology 25 (2020): e200950.
8. Singh AK., et al. “Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations”. Diabetes and Metabolic Syndrome: Clinical Research and Reviews4 (2020): 303-310.
9. Zhou F., et al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study”. Lancet10229 (2020): 1054-1062.

Citation

Citation: Anastasia N Agurbash and Michael A Ivanov. “Who is Developing Complications of Covid-19". Acta Scientific Gastrointestinal Disorders 4.11 (2021): 54-57.

Copyright

Copyright: © 2021 Anastasia N Agurbash and Michael A Ivanov. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.